Goldman Sachs

Goldman Sachs | 2/24/2020

… and investment management firm that provides a wide range of services worldwide.” ref Goldman Sachs, [http://www.goldmansachs.com/who-we-are/at-a-glance/index.html “At a glance”], organization website, accessed February 13, 2013 /ref Goldman Sachs has become “the most profitable securities firm in Wall Street history.” ref ‘‘Bloomberg News’’, [http://www.bloomberg.com/apps/news?pid=newsarchive&sid=aZBeMz6nEWr8 “Goldman Sachs Courts Endowment Heads to Boost Assets”], April 12, 2010. /ref …

Goldman Sachs Selects Everbridge CEM Suite | 12/4/2019

Blog This Everbridge , Inc. (NASDAQ: EVBG), the global leader in critical event management, today announced that Goldman Sachs will employ the services offered by Everbridge to enhance its ability to monitor operational risk, business continuity and employee safety events for its people and assets around the globe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191204005468/en/ https://www.everbridge.com Everbridge Critical Event Management (CEM …

Follow Goldman Sachs:    

63 Biggest Movers From Yesterday | 12/4/2019

… plc (NASDAQ: ITRM ) rose 20.2% to close at $3.15. Wrap Technologies, Inc. (NASDAQ: WRTC ) shares surged 17.2% to close at $5.05. uniQure N.V. (NASDAQ: QURE ) rose 16.7% to close at $63.92 after analysts from Goldman Sachs and Cowen & Co initiated coverage on the company’s stock with bullish ratings. Super League Gaming, Inc. (NASDAQ: SLGG ) gained 15.8% to close at $2.71. Mesa Air Group, Inc. (NASDAQ: MESA ) climbed 15.6% to close …

🌎 Workday Downgraded, Marvell Technology Group Downgraded, Owens Corning Downgraded and more… | 12/4/2019

… Read More . IAA ( NYSE:IAA ) was upgraded by analysts at Northcoast Research from a “neutral” rating to a “buy” rating. current price of $46.89. Read More . NetEase ( NASDAQ:NTES ) was upgraded by analysts at Goldman Sachs Group Inc from a “neutral” rating to a “buy” rating. They now have a $368.00 price target on the stock, up previously from $300.00. 14.6% upside from the current price of $321.07. Read More …

AWS Works Hard To Keep Ahead Of The Public Cloud Herd | 12/4/2019

… making a strong push to grow its enterprise customer base, and in China there are other large players with deep pockets, notably Alibaba and Tencent. AWS can count a lot of major corporations – GE, Goldman Sachs , Capital One, Pfizer and Shell, to name a few – as customers as well as notable high-profile cloud-based companies like Lyft, Uber, Airbnb, and Peloton. But there’s a long way to go in …

Murphy takes control of Democratic Governors Association | 12/4/2019

… going to win races for governor next year, Gov. Phil Murphy said in an interview ahead of his leadership role on the national arm in charge of electing Democrats to governorships. Murphy, a former Goldman Sachs executive and Obama administration ambassador, is in his first term as governor and will succeed Rhode Island Gov. Gina Raimondo as head of the Democratic Governors Association on Tuesday. He spoke to The Associated …

Edison Partners Promotes Jennifer Lee to Principal | PRWeb | 12/4/2019

… accolades in investment and Fintech communities. In October, she was named a Business Insider Rising Star on Wall Street , an esteemed list of 25 young financial professionals from firms including Apollo Global Management, Blackstone, Goldman Sachs and BlackRock. Last month, NYC Fintech Women included her on their Inspiring Fintech Females 2019 list, drawn from 3,000 members across startups and investment firms. Earlier this fall, she was named a Finovate finalist …

Synchrony Financial to Participate in the Goldman Sachs US Financial Services Conference – Company Announcement - FT.com | Financial Times | 12/4/2019

STAMFORD, Conn. , Dec. 3, 2019 /PRNewswire/ – Synchrony Financial (NYSE: SYF ) Chief Executive Officer, Margaret M. Keane , and Executive Vice President and Chief Financial Officer, Brian J. Wenzel , will participate in the Goldman Sachs US Financial Services Conference in New York on Tuesday, December 10, 2019 at 1:30 p.m. (Eastern Time) . A live webcast and replay will be made available on the Synchrony Financial Investor Relations website at www.investors.synchronyfinancial.com . About Synchrony …

Elior Group: Results; Objectives Achieved for Full-Year 2018-2019; New Elior Ambitions Confirmed – Company Announcement - FT.com | Financial Times | 12/4/2019

… development In the fourth quarter of 2018-2019, Elior Group signed a number of major catering and services contracts, notably with: Sense, the municipality of Chennevières sur Marne, and the Seb corporate headquarters in France Goldman Sachs , LinkedIn and Cisco in India AGCO Laverda and ICS International School in Italy Bowie State University , California Academy of Sciences and Aspire in the United States Catalonia national art museum, Cirque du Soleil and …

Arrowhead Pharmaceuticals Announces Pricing of Underwritten Public Offering of Common Stock – Company Announcement - FT.com | Financial Times | 12/4/2019

… terms of the offering will be filed with the SEC and will be available on the SEC’s web site at www.sec.gov . When available, copies of the final prospectus supplement may also be obtained from Goldman Sachs & Co. LLC by mail at 200 West Street , New York, NY 10282, Attention: Prospectus Department, by telephone at (866) 471-2526, or by email at [email protected] ; from Jefferies LLC , Attention: Equity Syndicate Prospectus …

Koninklijke Philips (AMS:PHIA) PT Set at €39.40 by JPMorgan Chase & Co. | 12/4/2019

… Chase & Co. in a research note issued on Wednesday, Borsen Zeitung reports. The firm presently has a “neutral” rating on the stock. A number of other equities research analysts have also commented on PHIA. Goldman Sachs Group set a €49.00 ($56.98) price target on Koninklijke Philips and gave the company a “buy” rating in a research report on Tuesday, October 29th. Deutsche Bank set a €47.00 ($54.65) price objective on …

GlaxoSmithKline (LON:GSK) Earns Buy Rating from UBS Group - TheOlympiaReport | 12/4/2019

… a GBX 1,900 ($24.83) price target on the stock. UBS Group’s target price would indicate a potential upside of 11.29% from the stock’s previous close. Several other equities analysts have also commented on GSK. Goldman Sachs Group set a GBX 1,900 ($24.83) target price on GlaxoSmithKline and gave the company a “buy” rating in a research note on Wednesday, October 30th. Shore Capital reissued a “hold” rating on shares of …

Analysts Anticipate Myovant Sciences Ltd (NYSE:MYOV) to Announce -$0.81 EPS - TheOlympiaReport | 12/4/2019

… its earnings results on Tuesday, November 12th. The company reported ($0.79) earnings per share for the quarter, missing the consensus estimate of ($0.72) by ($0.07). Several research analysts recently weighed in on the company. Goldman Sachs Group reiterated a “buy” rating and issued a $20.00 price objective (up from $18.00) on shares of Myovant Sciences in a research report on Tuesday, November 19th. JMP Securities restated a “buy” rating and …

Research Analysts Offer Predictions for Amgen, Inc.’s FY2019 Earnings (NASDAQ:AMGN) | 12/4/2019

… a “market perform” rating and issued a $220.00 price objective (up from $202.00) on shares of Amgen in a research report on Tuesday, August 27th. They noted that the move was a valuation call. Goldman Sachs Group set a $243.00 target price on Amgen and gave the company a “buy” rating in a research note on Monday, September 30th. Credit Suisse Group restated an “outperform” rating and set a $225.00 …

Amgen (NASDAQ:AMGN) Hits New 12-Month High at $236.00 - Ticker Report | 12/4/2019

… 12th. They issued a “buy” rating and a $256.00 target price for the company. JPMorgan Chase & Co. reaffirmed a “hold” rating on shares of Amgen in a research note on Monday, September 30th. Finally, Goldman Sachs Group set a $243.00 price target on shares of Amgen and gave the stock a “buy” rating in a research note on Monday, September 30th. Ten equities research analysts have rated the stock with …

Amgen (NASDAQ:AMGN) Sets New 1-Year High at $236.00 | Daily Political | 12/4/2019

… company a “buy” rating in a research note on Monday, September 9th. BidaskClub upgraded shares of Amgen from a “buy” rating to a “strong-buy” rating in a report on Wednesday, November 13th. Finally, Goldman Sachs Group set a $243.00 price objective on shares of Amgen and gave the stock a “buy” rating in a report on Monday, September 30th. Ten analysts have rated the stock with a hold rating …

Croda International (LON:CRDA) Given Neutral Rating at Citigroup - Ticker Report | 12/4/2019

Citigroup reaffirmed their neutral rating on shares of Croda International (LON:CRDA) in a research note issued to investors on Tuesday, ThisIsMoney.Co.Uk reports. Other equities analysts also recently issued reports about the company. Goldman Sachs Group downgraded Croda International to a sell rating Tuesday, September 3rd. Credit Suisse Group restated an underperform rating and issued a GBX 4,000 ($52.27) target price on shares of Croda International Monday, September 2nd. UBS …

Is The Goldman Sachs Group, Inc. (NYSE:GS) An Attractive Dividend Stock? | Yahoo News | 12/4/2019

Today we’ll take a closer look at The Goldman Sachs Group, Inc. ( a target=”_blank” href=”https://simplywall.st/stocks/us/diversified-financials/nyse-gs/goldman-sachs-group?utm_medium=finance_user&utm_campaign=intro&utm_source=yahoo&blueprint=942857” rel=”nofollow noopener” NYSE:GS /a ) from a dividend investor’s perspective. Owning a strong business and reinvesting the dividends is widely seen as an attractive way of growing your wealth. If …

Portola Pharmaceuticals Inc (NASDAQ:PTLA) Receives Consensus Recommendation of “Hold” from Analysts | 12/4/2019

… sell” rating in a research report on Monday, October 21st. Cowen reissued a “buy” rating and set a $45.00 price target on shares of Portola Pharmaceuticals in a research report on Tuesday, November 5th. Goldman Sachs Group began coverage on Portola Pharmaceuticals in a research note on Friday, November 8th. They set a “neutral” rating and a $35.00 price target on the stock. Citigroup decreased their price objective on Portola …

In the Midst of the Biggest Wall Street Bailout Since the Financial Crisis, the Fed Presents Alice-in-Wonderland Testimony for Today’s House Hearing | 12/4/2019

… firm, Davis Polk & Wardwell, which represents many of the nation’s largest banks.” Later in the article, Smialek adds this: “He has talked with Davis Polk more often than other law firms, but executives from Goldman Sachs and JPMorgan have also met with him about 20 times each.” Today, Quarles will be probed on his supervisory work by the House Financial Services Committee. The questioning comes at a time when the …

Medical Research

Parametric Portfolio Associates LLC Buys 3,627 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) | 12/4/2019

… according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 86,124 shares of the medical research company’s stock after purchasing an additional 3,627 shares during the period. Parametric Portfolio … hold” rating in a research note on Tuesday, October 1st. Goldman Sachs Group upgraded Bio-Rad Laboratories from a “buy” rating to a “conviction-buy” rating and set a $400.00 price target on the stock …

Wolfe Research

PRA Health Sciences Inc (NASDAQ:PRAH) Given Average Rating of “Buy” by Analysts - Dakota Financial News | 12/4/2019

… coverage on the stock in the last year is $115.78. Several equities research analysts have issued reports on PRAH shares. Wolfe Research upgraded shares of PRA Health Sciences from a “peer perform” rating to an … overweight” rating in a research report on Wednesday, September 4th. Goldman Sachs Group started coverage on PRA Health Sciences in a research note on Thursday, September 19th. They set a “buy” rating and a $126.00 …

Patterson Companies (PDCO) Scheduled to Post Quarterly Earnings on Thursday | Daily Political | 12/3/2019

Goldman Sachs Group set a $15.00 price objective on shares of Patterson Companies and gave the stock a “sell” rating in a report on Friday, August 30th. Wolfe Research set a $17.00 target price on shares of Patterson Companies and gave the company a “sell” rating in a report on Friday, August 30th. UBS Group lowered their target price on shares of Patterson Companies from $23.00 to $16.00 and set …

Medicare

30 companies worth at least $1 billion that didn’t exist 10 years ago | Business Insider | 12/4/2019

… the company’s “toxic” environment. Since the scandal, Anthony Noto — former chief operating officer of Twitter and former managing director at Goldman Sachs — has taken over and shown interest in SoFi entering the cryptocurrency game . Scooter … Schlosser announced Oscar’s marketplace would start selling Obamacare plans, including Medicare Advantage plans, in 12 new markets starting in 2020 . Additional reporting by Lydia Ramsey and Clarrie Feinstein. Robotic food-preparation company Zume, known for …

30 companies worth at least $1 billion that didn’t exist 10 years ago | Markets Insider | Business Insider | 12/3/2019

… the company’s “toxic” environment. Since the scandal, Anthony Noto - former chief operating officer of Twitter and former managing director at Goldman Sachs - has taken over and shown interest in SoFi entering the cryptocurrency game . Scooter … Schlosser announced Oscar’s marketplace would start selling Obamacare plans, including Medicare Advantage plans, in 12 new markets starting in 2020 . Additional reporting by Lydia Ramsey and Clarrie Feinstein. Robotic food-preparation company Zume, known for …

Personal Care

30 companies worth at least $1 billion that didn’t exist 10 years ago | Business Insider | 12/4/2019

… the company’s “toxic” environment. Since the scandal, Anthony Noto — former chief operating officer of Twitter and former managing director at Goldman Sachs — has taken over and shown interest in SoFi entering the cryptocurrency game . Scooter … to PitchBook. Hims, the online platform where men can order personal care products discreetly, reached unicorn status in January 2019 and is currently valued at $1.1 billion. Hollis Johnson/Business Insider The success of Hims …

Croda International (LON:CRDA) Given Neutral Rating at Citigroup - Ticker Report | 12/4/2019

… a research note issued to investors on Tuesday, ThisIsMoney.Co.Uk reports. Other equities analysts also recently issued reports about the company. Goldman Sachs Group downgraded Croda International to a sell rating Tuesday, September 3rd. Credit Suisse … Asia, and Latin America. The company operates in four segments: Personal Care, Life Sciences, Performance Technologies, and Industrial Chemicals. It offers adhesives; crop protection additives and adjuvants, seed enhancement and animal health chemicals, chemical bio …

CRISPR

Crispr Therapeutics AG (NASDAQ:CRSP) Expected to Announce Quarterly Sales of $59.43 Million | 12/4/2019

Wall Street brokerages expect Crispr Therapeutics AG (NASDAQ:CRSP) to report sales of $59.43 million for the current fiscal quarter, according to Zacks Investment Research . Four analysts have made estimates for Crispr Therapeutics’ earnings, with … 65.00 to $100.00 in a report on Tuesday, November 19th. Goldman Sachs Group raised their price objective on shares of Crispr Therapeutics from $52.00 to $75.00 and gave the company a “neutral” rating in a …

BidaskClub Upgrades Crispr Therapeutics (NASDAQ:CRSP) to Strong-Buy - Ticker Report | 12/2/2019

Crispr Therapeutics (NASDAQ:CRSP) was upgraded by equities research analysts at BidaskClub from a “buy” rating to a “strong-buy” rating in a report released on Saturday, BidAskClub reports. A number of other brokerages also … perform” rating to an “outperform” note on Tuesday, November 19th. Goldman Sachs Group lifted their price target on shares of Crispr Therapeutics from $52.00 to $75.00 and gave the stock a “neutral” note on Tuesday …

Consumer Healthcare

GlaxoSmithKline (LON:GSK) Earns Buy Rating from UBS Group - TheOlympiaReport | 12/4/2019

… indicate a potential upside of 11.29% from the stock’s previous close. Several other equities analysts have also commented on GSK. Goldman Sachs Group set a GBX 1,900 ($24.83) target price on GlaxoSmithKline and gave the … operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. Further Reading: Find a Trading Strategy That Works …

GlaxoSmithKline (LON:GSK) Receives Buy Rating from UBS Group - WKRB News | 12/3/2019

… a GBX 1,900 ($24.83) price objective on the stock. Other research analysts have also recently issued reports about the stock. Goldman Sachs Group set a GBX 1,900 ($24.83) target price on shares of GlaxoSmithKline and … operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. Featured Article: What is Call Option Volume …

Food and Drug Administration

30 companies worth at least $1 billion that didn’t exist 10 years ago | Business Insider | 12/4/2019

… more controversial startups of this decade, Juul, the e-cigarette company, sparked national outrage, congressional investigations, and criticism by the Food and Drug Administration, leading to total product bans in some countries . Juul’s rise was … chief operating officer of Twitter and former managing director at Goldman Sachs — has taken over and shown interest in SoFi entering the cryptocurrency game . Scooter and bike rental startup Lime is valued at $2.4 billion …

30 companies worth at least $1 billion that didn’t exist 10 years ago | Markets Insider | Business Insider | 12/3/2019

… more controversial startups of this decade, Juul, the e-cigarette company, sparked national outrage, congressional investigations, and criticism by the Food and Drug Administration, leading to total product bans in some countries . Juul’s rise was … chief operating officer of Twitter and former managing director at Goldman Sachs - has taken over and shown interest in SoFi entering the cryptocurrency game . Scooter and bike rental startup Lime is valued at $2.4 billion …

Clinical Research

PRA Health Sciences Inc (NASDAQ:PRAH) Given Average Rating of “Buy” by Analysts - Dakota Financial News | 12/4/2019

… Sciences from $115.00 to $118.00 and gave the company an “overweight” rating in a research report on Wednesday, September 4th. Goldman Sachs Group started coverage on PRA Health Sciences in a research note on Thursday … and pharmaceutical industries worldwide. The company operates in two segments, Clinical Research and Data Solutions. The Clinical Research segment offers product registration services, including clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations …

Voya Investment Management LLC Boosts Stock Holdings in PRA Health Sciences Inc (NASDAQ:PRAH) | 12/3/2019

… hold” rating and set a $108.00 price target for the company. in a research report on Tuesday, November 5th. Finally, Goldman Sachs Group initiated coverage on PRA Health Sciences in a research report on Thursday … and pharmaceutical industries worldwide. The company operates in two segments, Clinical Research and Data Solutions. The Clinical Research segment offers product registration services, including clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations …

Genomics

30 companies worth at least $1 billion that didn’t exist 10 years ago | Business Insider | 12/4/2019

… the company’s “toxic” environment. Since the scandal, Anthony Noto — former chief operating officer of Twitter and former managing director at Goldman Sachs — has taken over and shown interest in SoFi entering the cryptocurrency game . Scooter … 3.6 billion when it went public, gene sequencing startup 10x Genomics continues to help doctors and scientists understand cancers and cell therapy. Serge Saxonov, cofounder & CEO of 10x Genomics. YouTube/Bloomberg Technology Launched in 2012 …

Crack down on genomic surveillance | Nature | 12/3/2019

… many other types of personal data, including an individual’s posting behaviour on social networks. Last year, the Chinese firm Forensic Genomics International (FGI) announced that it was storing the DNA profiles of more than 100,000 … March this year, for example, major US funds such as Goldman Sachs have divested all their shares from the Chinese surveillance company Hikvision, because of concerns about the use of the company’s products in human …

Health Informatics

Koninklijke Philips (AMS:PHIA) PT Set at €39.40 by JPMorgan Chase & Co. | 12/4/2019

… presently has a “neutral” rating on the stock. A number of other equities research analysts have also commented on PHIA. Goldman Sachs Group set a €49.00 ($56.98) price target on Koninklijke Philips and gave the … segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care & Health Informatics businesses, HealthTech Other and Legacy Items. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support …

Koninklijke Philips (AMS:PHIA) Given a €39.40 Price Target at JPMorgan Chase & Co. | 11/25/2019

… on shares of Koninklijke Philips and gave the company a buy rating in a research note on Friday, October 11th. Goldman Sachs Group set a €49.00 ($56.98) target price on shares of Koninklijke Philips and … segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care & Health Informatics businesses, HealthTech Other and Legacy Items. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support …

GlaxoSmithKline

GlaxoSmithKline (LON:GSK) Earns Buy Rating from UBS Group - TheOlympiaReport | 12/4/2019

GlaxoSmithKline (LON:GSK) ‘s stock had its “buy” rating reaffirmed by analysts at UBS Group in a report issued on Monday, Borsen Zeitung reports. They currently have a GBX 1,900 ($24.83) price target on the stock. UBS Group’s target price would indicate a potential upside of 11.29% from the stock’s previous close. Several other equities analysts have also commented on GSK. Goldman Sachs Group set a GBX 1,900 ($24.83) target …

7 of the Best Bond ETFs to Buy Now | Yahoo News | 12/4/2019

… to debt that matures in three years or less to firms like tech giant Oracle Corp. ( ORCL ) and financial giant Goldman Sachs Group ( GS ). A lot can happen to even these currently stable companies in … U.K. financial giant Lloyd’s Banking Group ( LYG ) and pharma powerhouse GlaxoSmithKline ( GSK ). With a portfolio of more than 430 individual bonds, this is a great way to add some geographic diversification to your portfolio. It’s …

Pfizer

AWS Works Hard To Keep Ahead Of The Public Cloud Herd | 12/4/2019

… Goldman Sachs, Capital One, Pfizer and Shell, to name a few – as customers as well as notable high-profile cloud-based companies like Lyft, Uber, Airbnb, and Peloton. But there’s a long way to go in the cloud and Jassy and other executives know that a significant market share lead is not guaranteed. His keynote was what the 65,000 attendees have come to expect at Re:Invent: a recounting of …

MAYOR PETE BUTTIGIEG DECLARES THAT HIS HEALTH PLAN WILL INCLUDE ILLEGALS AND HIS AMNESTY WILL ENABLE THE REST OF MEXICO TO JUMP U.S. OPEN BORDERS AND VOTE DEM FOR MORE | 12/3/2019

… Goldman Sachs, GE, Pfizer, the United Auto Workers—the same “special interests” Barack Obama was supposed to chase from the temple—are profiting handsomely from Obama’s Big Government policies that crush taxpayers, small businesses, and consumers. In Obamanomics, investigative reporter Timothy P. Carney digs up the dirt the mainstream media ignores and the White House wishes you wouldn’t see. Rather than Hope and Change, Obama is delivering corporate socialism to …

Siemens

Siemens Healthineers (ETR:SHL) Given a €35.80 Price Target by JPMorgan Chase & Co. Analysts | 12/4/2019

Posted by ABMN Staff on Dec 4th, 2019 // No Comments Siemens Healthineers (ETR:SHL) received a €35.80 ($41.63) price target from investment analysts at JPMorgan Chase & Co. in a research note issued on Wednesday, Borsen … of Siemens Healthineers in a report on Monday, November 4th. Goldman Sachs Group set a €38.00 ($44.19) price target on Siemens Healthineers and gave the stock a “neutral” rating in a research note on Monday …

Siemens Healthineers AG (ETR:SHL) Receives €39.49 Consensus Price Target from Brokerages - TheOlympiaReport | 11/29/2019

Siemens Healthineers AG (ETR:SHL) has received a consensus rating of “Hold” from the seventeen analysts that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation … of Siemens Healthineers in a report on Monday, November 4th. Goldman Sachs Group set a €38.00 ($44.19) price objective on Siemens Healthineers and gave the company a “neutral” rating in a report on Monday, November …

UnitedHealth

10 Biggest Price Target Changes For Wednesday | Benzinga | 12/4/2019

… target from $83 to $89. Tyson Foods shares closed at $88.95 on Tuesday. Cantor Fitzgerald boosted the price target on UnitedHealth Group Inc (NYSE: UNH ) from $310 to $315. UnitedHealth closed at $276.90 on Tuesday … 9 to $5. ViewRay shares closed at $4.44 on Tuesday. Goldman Sachs raised NetEase Inc (NASDAQ: NTES ) price target from $300 to $368. NetEase shares closed at $317.32 on Tuesday. KeyBanc boosted the price target …

🌎 Workday Downgraded, Marvell Technology Group Downgraded, Owens Corning Downgraded and more… | 12/4/2019

… neutral” rating to a “buy” rating. current price of $46.89. Read More . NetEase ( NASDAQ:NTES ) was upgraded by analysts at Goldman Sachs Group Inc from a “neutral” rating to a “buy” rating. They now have … 25.1% upside from the current price of $43.16. Read More . UnitedHealth Group ( NYSE:UNH ) had its price target raised by analysts at UBS Group AG from $257.00 to $279.00. They now have a “neutral” rating …

Amgen

Research Analysts Offer Predictions for Amgen, Inc.’s FY2019 Earnings (NASDAQ:AMGN) | 12/4/2019

Amgen, Inc. (NASDAQ:AMGN) – Investment analysts at Oppenheimer lifted their FY2019 earnings per share estimates for shares of Amgen in a research report issued on Sunday, December 1st. Oppenheimer analyst J. Olson now expects that … 27th. They noted that the move was a valuation call. Goldman Sachs Group set a $243.00 target price on Amgen and gave the company a “buy” rating in a research note on Monday, September 30th …

Amgen (NASDAQ:AMGN) Hits New 12-Month High at $236.00 - Ticker Report | 12/4/2019

Amgen, Inc. (NASDAQ:AMGN) reached a new 52-week high on Monday . The stock traded as high as $236.00 and last traded at $233.96, with a volume of 6987 shares changing hands. The stock had … Amgen in a research note on Monday, September 30th. Finally, Goldman Sachs Group set a $243.00 price target on shares of Amgen and gave the stock a “buy” rating in a research note on Monday …

Siemens Healthineers

Siemens Healthineers (ETR:SHL) Given a €35.80 Price Target by JPMorgan Chase & Co. Analysts | 12/4/2019

Posted by ABMN Staff on Dec 4th, 2019 // No Comments Siemens Healthineers (ETR:SHL) received a €35.80 ($41.63) price target from investment analysts at JPMorgan Chase & Co. in a research note issued on Wednesday, Borsen … of Siemens Healthineers in a report on Monday, November 4th. Goldman Sachs Group set a €38.00 ($44.19) price target on Siemens Healthineers and gave the stock a “neutral” rating in a research note on Monday …

Siemens Healthineers AG (ETR:SHL) Receives €39.49 Consensus Price Target from Brokerages - TheOlympiaReport | 11/29/2019

Siemens Healthineers AG (ETR:SHL) has received a consensus rating of “Hold” from the seventeen analysts that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation … of Siemens Healthineers in a report on Monday, November 4th. Goldman Sachs Group set a €38.00 ($44.19) price objective on Siemens Healthineers and gave the company a “neutral” rating in a report on Monday, November …

UnitedHealth Group

10 Biggest Price Target Changes For Wednesday | Benzinga | 12/4/2019

… target from $83 to $89. Tyson Foods shares closed at $88.95 on Tuesday. Cantor Fitzgerald boosted the price target on UnitedHealth Group Inc (NYSE: UNH ) from $310 to $315. UnitedHealth closed at $276.90 on Tuesday … 9 to $5. ViewRay shares closed at $4.44 on Tuesday. Goldman Sachs raised NetEase Inc (NASDAQ: NTES ) price target from $300 to $368. NetEase shares closed at $317.32 on Tuesday. KeyBanc boosted the price target …

🌎 Workday Downgraded, Marvell Technology Group Downgraded, Owens Corning Downgraded and more… | 12/4/2019

… neutral” rating to a “buy” rating. current price of $46.89. Read More . NetEase ( NASDAQ:NTES ) was upgraded by analysts at Goldman Sachs Group Inc from a “neutral” rating to a “buy” rating. They now have … 25.1% upside from the current price of $43.16. Read More . UnitedHealth Group ( NYSE:UNH ) had its price target raised by analysts at UBS Group AG from $257.00 to $279.00. They now have a “neutral” rating …

GSK

GlaxoSmithKline (LON:GSK) Earns Buy Rating from UBS Group - TheOlympiaReport | 12/4/2019

GlaxoSmithKline (LON:GSK) ‘s stock had its “buy” rating reaffirmed by analysts at UBS Group in a report issued on Monday, Borsen Zeitung reports. They currently have a GBX 1,900 ($24.83) price target on the stock. UBS Group’s target price would indicate a potential upside of 11.29% from the stock’s previous close. Several other equities analysts have also commented on GSK. Goldman Sachs Group set a GBX 1,900 ($24.83) target …

GlaxoSmithKline (LON:GSK) Receives Buy Rating from UBS Group - WKRB News | 12/3/2019

UBS Group reiterated their buy rating on shares of GlaxoSmithKline (LON:GSK) in a report issued on Monday morning, Borsen Zeitung reports. UBS Group currently has a GBX 1,900 ($24.83) price objective on the stock. Other research analysts have also recently issued reports about the stock. Goldman Sachs Group set a GBX 1,900 ($24.83) target price on shares of GlaxoSmithKline and gave the company a buy rating in a report …

Biogen

Google Alert - stock | 12/4/2019

… the world and bonds rallied after President Donald Trump aimed his tariff weapon on economies from South … Flag as irrelevant Biogen Stock Falls After Analyst Throws Cold Water on Its Alzheimer’s Drug Bet Fortune This … consumer-driven economy and thus the stock … Flag as irrelevant Goldman Sachs: 3 Stocks with Double-Digit Potential in 2020 Yahoo Finance 2019 has been a fantabulous year for stock investors, with the S&P …

Goldman neutral on Bausch Health in premarket analyst action - Bausch Health Companies Inc. (NYSE:BHC) | Seeking Alpha | 12/2/2019

Bausch Health Companies (NYSE: BHC ) initiated with Neutral rating and C$40 (7% upside) price target at Goldman Sachs. Shares up 2% premarket. Centogene N.V. (NASDAQ: CNTG ) initiated with Buy rating and $18 (38% upside … a C$22.60 (33% upside) price target at Compass Point. Biogen (NASDAQ: BIIB ) downgraded to Underperform with a $250 (17% downside risk) price target at Baird. Teladoc (NYSE: TDOC ) downgraded to Hold with an $80 …

HealthEquity

Healthequity (NASDAQ:HQY) Stock Rating Reaffirmed by Barrington Research - Dakota Financial News | 12/4/2019

Healthequity (NASDAQ:HQY) ‘s stock had its “buy” rating reissued by research analysts at Barrington Research in a note issued to investors on Monday, AnalystRatings.com reports. They currently have a $75.00 price objective on the … buy” rating in a research report on Wednesday, September 4th. Goldman Sachs Group assumed coverage on shares of Healthequity in a research report on Monday, October 7th. They issued a “neutral” rating and a $56.00 …

10 Biggest Price Target Changes For Wednesday | Benzinga | 12/4/2019

Goldman Sachs raised NetEase Inc (NASDAQ: NTES ) price target from $300 to $368. NetEase shares closed at $317.32 on Tuesday. KeyBanc boosted the price target for Healthequity Inc (NASDAQ: HQY ) from $70 to $77. Healthequity shares closed at $61.24 on Tuesday. Imperial Capital raised the price target for Madison Square Garden Co (NYSE: MSG ) from $357 to $360. Madison Square Garden shares closed at $275.77 on Tuesday …

Morgan Stanley

🌎 Workday Downgraded, Marvell Technology Group Downgraded, Owens Corning Downgraded and more… | 12/4/2019

… rating to a “neutral” rating. current price of $3.09. Read More . Akzo Nobel ( OTCMKTS:AKZOY ) was upgraded by analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating. current price of $31.85 … Read More . NetEase ( NASDAQ:NTES ) was upgraded by analysts at Goldman Sachs Group Inc from a “neutral” rating to a “buy” rating. They now have a $368.00 price target on the stock, up previously from …

House Democrats Poised to Rubber-Stamp Weak Financial Regulation | 12/4/2019

… American Bankers Association and the four banks that dominate the swaps market — J.P. Morgan Chase, Bank of America, Citigroup, and Goldman Sachs — contributed $218,000 to agriculture committee members. The same group of donors gave more … and political action committees associated with Goldman Sachs, Citigroup, and Morgan Stanley. Meanwhile, Conaway has repeatedly backed measures favored by the banking industry. The House reauthorization bill changes how the CFTC considers the cost-benefit …

Citigroup

10 Biggest Price Target Changes For Wednesday | Benzinga | 12/4/2019

Citigroup raised the price target on Tesla Inc (NASDAQ: TSLA ) from $191 to $222. Tesla closed at $336.20 on Tuesday. Canaccord Genuity raised the price target for Penumbra Inc (NYSE: PEN ) from $175 to $200. Penumbra shares closed at $171.03 on Tuesday. B. Riley FBR lowered ViewRay, Inc. (NASDAQ: VRAY ) price target from $9 to $5. ViewRay shares closed at $4.44 on Tuesday. Goldman Sachs raised NetEase Inc (NASDAQ: NTES …

🌎 Workday Downgraded, Marvell Technology Group Downgraded, Owens Corning Downgraded and more… | 12/4/2019

… neutral” rating to a “buy” rating. current price of $46.89. Read More . NetEase ( NASDAQ:NTES ) was upgraded by analysts at Goldman Sachs Group Inc from a “neutral” rating to a “buy” rating. They now have … TSE:CNR) had its price target lowered by analysts at Citigroup Inc from $102.00 to $100.00. They now have a “buy” rating on the stock. 12.5% upside from the current price of $88.85. Read More …

Jefferies Financial Group

ZEALAND PHARMA/S (ZEAL) – Research Analysts’ Recent Ratings Changes | 12/4/2019

… their ratings and price targets for ZEALAND PHARMA/S (NASDAQ: ZEAL): 11/27/2019 – ZEALAND PHARMA/S was downgraded by analysts at Jefferies Financial Group Inc from a “buy” rating to a “hold” rating. 11/22/2019 – ZEALAND PHARMA … Denmark. “ 10/15/2019 – ZEALAND PHARMA/S was upgraded by analysts at Goldman Sachs Group Inc from a “neutral” rating to a “buy” rating. They now have a $41.00 price target on the stock. 10/12/2019 – ZEALAND PHARMA …

William Blair

Princeton Global Asset Management LLC Purchases 690 Shares of Amgen, Inc. (NASDAQ:AMGN) | 12/4/2019

Goldman Sachs Group set a $243.00 target price on Amgen and gave the stock a “buy” rating in a report on Monday, September 30th. Bank of America assumed coverage on Amgen in a research note on Wednesday, October 16th. They issued a “neutral” rating and a $215.00 target price for the company. William Blair reiterated a “hold” rating on shares of Amgen in a report on Friday, August 30th. Cantor …

Amgen (NASDAQ:AMGN) Sets New 1-Year High at $236.00 | Daily Political | 12/4/2019

William Blair reaffirmed a “hold” rating on shares of Amgen in a research note on Friday, August 30th. Oppenheimer set a $240.00 price target on shares of Amgen and gave the company a “buy” rating in a research note on Monday, September 9th. BidaskClub upgraded shares of Amgen from a “buy” rating to a “strong-buy” rating in a report on Wednesday, November 13th. Finally, Goldman Sachs Group set a …

JP Morgan

63 Biggest Movers From Yesterday | 12/4/2019

… shares surged 17.2% to close at $5.05. uniQure N.V. (NASDAQ: QURE ) rose 16.7% to close at $63.92 after analysts from Goldman Sachs and Cowen & Co initiated coverage on the company’s stock with bullish ratings. Super … Ltd (NASDAQ: DOYU ) dropped 4.1% to close at $7.20 after JP Morgan downgraded the company’s stock from Overweight to Neutral and lowered the price target from $10 to $8 …

10 Biggest Price Target Changes For Wednesday | Benzinga | 12/4/2019

JP Morgan raised Tyson Foods, Inc. (NYSE: TSN ) price target from $83 to $89. Tyson Foods shares closed at $88.95 on Tuesday. Cantor Fitzgerald boosted the price target on UnitedHealth Group Inc (NYSE: UNH ) from … 9 to $5. ViewRay shares closed at $4.44 on Tuesday. Goldman Sachs raised NetEase Inc (NASDAQ: NTES ) price target from $300 to $368. NetEase shares closed at $317.32 on Tuesday. KeyBanc boosted the price target …

SunTrust Bank

🌎 Workday Downgraded, Marvell Technology Group Downgraded, Owens Corning Downgraded and more… | 12/4/2019

… neutral” rating to a “buy” rating. current price of $46.89. Read More . NetEase ( NASDAQ:NTES ) was upgraded by analysts at Goldman Sachs Group Inc from a “neutral” rating to a “buy” rating. They now have … NASDAQ:AXSM ) had its price target raised by analysts at SunTrust Banks, Inc. to $60.00. They now have a “positive” rating on the stock. 32.9% upside from the current price of $45.13. Read More . Baidu …

Stock Analysts’ Updated EPS Estimates for December, 3rd (ADSK, ASBFY, ASPN, ASR, ATEYY, BAFYY, BCEL, BCYC, BFAM, BGSF) - Dakota Financial News | 12/4/2019

… Retail S.A. is based in Luxembourg. “ Hugo Boss (ETR:BOSS) was given a €54.00 ($62.79) target price by analysts at Goldman Sachs Group Inc. The firm currently has a neutral rating on the stock. Sierra … Concert Pharmaceuticals (NASDAQ:CNCE) had its target price increased by SunTrust Banks, Inc. to $25.00. They currently have a buy rating on the stock. Kering (EPA:KER) was given a €608.00 ($706.98) price target by …

SVB Leerink

Analysts Anticipate Myovant Sciences Ltd (NYSE:MYOV) to Announce -$0.81 EPS - TheOlympiaReport | 12/4/2019

… for the quarter, missing the consensus estimate of ($0.72) by ($0.07). Several research analysts recently weighed in on the company. Goldman Sachs Group reiterated a “buy” rating and issued a $20.00 price objective (up from … Myovant Sciences in a report on Tuesday, November 12th. Finally, Svb Leerink initiated coverage on Myovant Sciences in a report on Monday, August 19th. They set an “outperform” rating and a $26.00 price target for …

Myovant Sciences (NYSE:MYOV) Shares Gap Down to $19.21 | Daily Political | 12/3/2019

… Svb Leerink started coverage on shares of Myovant Sciences in Monday, August 19th. They set an “outperform” rating and a $26.00 price target on the stock. Cowen reiterated a “buy” rating on shares of Myovant Sciences in a research note on Tuesday, November 12th. Goldman Sachs Group reissued a “buy” rating and issued a $20.00 price objective (up from $18.00) on shares of Myovant Sciences in a report on Tuesday …

JMP Securities

Analysts Anticipate Myovant Sciences Ltd (NYSE:MYOV) to Announce -$0.81 EPS - TheOlympiaReport | 12/4/2019

Goldman Sachs Group reiterated a “buy” rating and issued a $20.00 price objective (up from $18.00) on shares of Myovant Sciences in a research report on Tuesday, November 19th. JMP Securities restated a “buy” rating and issued a $34.00 target price on shares of Myovant Sciences in a research report on Tuesday, November 19th. ValuEngine lowered Myovant Sciences from a “buy” rating to a “hold” note on Tuesday. Cowen reiterated …

19 Healthcare Stocks Moving In Tuesday’s Pre-Market Session | Benzinga | 12/3/2019

… NASDAQ: QURE ) stock increased by 18.7% to $65.00. The market cap stands at $2.1 billion. The most recent rating by Goldman Sachs, on December 03, is at Buy, with a price target of $98.00. Axsome … at $46.7 million. According to the most recent rating by JMP Securities, on November 14, the current rating is at Market Perform. Pluristem Therapeutics, Inc. (NASDAQ: PSTI ) stock rose 2.2% to $3.69. The market cap …

Bain Capital

House Democrats Poised to Rubber-Stamp Weak Financial Regulation | 12/4/2019

… American Bankers Association and the four banks that dominate the swaps market — J.P. Morgan Chase, Bank of America, Citigroup, and Goldman Sachs — contributed $218,000 to agriculture committee members. The same group of donors gave more … also received sizable donations from executives at the hedge fund Bain Capital, a player in the growing market for financial technologies, or fintech, including virtual currencies like bitcoin. In recent years, Bain has invested hundreds …

Kamala Harris drops out of 2020 Democratic presidential race | 12/3/2019

… Inauguration Day: 63 Entered race: Told friends he was running on November 13, 2019 Career: Currently a managing director of Bain Capital. Awarded scholarship in eighth grade to Massachusetts boarding school Milton Academy, becoming first … Yang, and Yale, then Stanford Business School. Morgan Stanley and Goldman Sachs banker who founded his own hedge fund in 1986 and made himself a billionaire; investments included subprime lenders, private prisons and coal mines …

Imperial Capital

10 Biggest Price Target Changes For Wednesday | Benzinga | 12/4/2019

Goldman Sachs raised NetEase Inc (NASDAQ: NTES ) price target from $300 to $368. NetEase shares closed at $317.32 on Tuesday. KeyBanc boosted the price target for Healthequity Inc (NASDAQ: HQY ) from $70 to $77. Healthequity shares closed at $61.24 on Tuesday. Imperial Capital raised the price target for Madison Square Garden Co (NYSE: MSG ) from $357 to $360. Madison Square Garden shares closed at $275.77 on Tuesday …

Research Analysts’ Updated EPS Estimates for November, 27th (BITA, BREW, CAL, CALA, CDR, CHEF, CLGN, CSLT, DIS, IMXI) | 11/28/2019

Imperial Capital from $141.00 to $143.00. Cowen Inc started coverage on shares of International Money Express (NASDAQ:IMXI) . They issued an outperform rating and a $17.00 target price on the stock. Kohl’s (NYSE:KSS) had its target price lowered by Goldman Sachs Group Inc from $56.00 to $48.00. Lowe’s Companies (NYSE:LOW) had its price target boosted by Goldman Sachs Group Inc from $123.00 to $135.00. PagSeguro Digital (NYSE:PAGS …

Memorial Sloan Kettering

Top Women in Metro New York Foodservice & Hospitality 2020 | 12/4/2019

… NY Stephanie Giraulo • St. Charles Hospital • Port Jefferson, NY Dr. Carol Letzter • Textured Food Innovations • Carle Place, NY Veronica McLymont • Memorial Sloan Kettering Cancer Center • New York, NY Angela O’Neil • Hunterdon Medical Center • Flemington, NJ … York Staffing Association (NYSA) and is an Alumni of the Goldman Sachs 10,000 Small Businesses program. She has been honored as a SmartCEO New York Brava and SHFM Spirit Award Winner. Maureen Drum • Institute Of …

Physician Prepping Healthcare Vehicle | 11/20/2019

… is set to launch with as much as $300 million of day-one capital, a source said. Jia has hired Goldman Sachs and J.P. Morgan to clear trades. He plans to focus on the stocks … Sciences in 2008. He was conducting post-doctoral research at Memorial Sloan Kettering Cancer Center when he decided to make the switch to finance. In his new role at Octagon, Jia is telling investors his …

Tenet Healthcare

Tenet Healthcare Corp (NYSE:THC) Shares Bought by New Mexico Educational Retirement Board - Ticker Report | 12/3/2019

New Mexico Educational Retirement Board lifted its holdings in Tenet Healthcare Corp (NYSE:THC) by 22.2% in the 3rd quarter, Holdings Channel.com reports. The fund owned 17,600 shares of the company’s stock after buying an … to $36.00 in a research report on Wednesday, November 6th. Goldman Sachs Group began coverage on shares of Tenet Healthcare in a research note on Wednesday, August 14th. They issued a “neutral” rating and a …

Tenet Healthcare Corp (NYSE:THC) Receives Average Rating of “Hold” from Analysts | 12/2/2019

Tenet Healthcare Corp (NYSE:THC) has been assigned an average recommendation of “Hold” from the fifteen analysts that are presently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell … been the topic of a number of recent research reports. Goldman Sachs Group initiated coverage on shares of Tenet Healthcare in a research note on Wednesday, August 14th. They set a “neutral” rating and a …

Tenet Healthcare Corporation

Tenet Healthcare Corp (NYSE:THC) Shares Bought by New Mexico Educational Retirement Board - Ticker Report | 12/3/2019

… and increased their price objective for the stock from $25.00 to $36.00 in a research report on Wednesday, November 6th. Goldman Sachs Group began coverage on shares of Tenet Healthcare in a research note on … and an average price target of $30.83. About Tenet Healthcare Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its …

Tenet Healthcare Corp (NYSE:THC) Receives Average Rating of “Hold” from Analysts | 12/2/2019

… the stock in the last year is $30.64. THC has been the topic of a number of recent research reports. Goldman Sachs Group initiated coverage on shares of Tenet Healthcare in a research note on … by institutional investors and hedge funds. Tenet Healthcare Company Profile Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its …

Intermountain Healthcare

POLITICO Playbook: Republicans want Schiff to testify - POLITICO | 12/1/2019

… You can’t take proper care of patients if you don’t document care,’ said Stan Huff, chief medical informatics officer at Intermountain Healthcare in Utah, who reviewed the paper trail of many of the deaths for … his political allies and trash his detractors.” WaPo WASHINGTON INC. – “Goldman Sachs seeks to rebrand as wealth takes center stage in the Democratic presidential race,” by WaPo’s Tory Newmyer in Ankeny, Iowa: “An unlikely corporate …

Ascension

Dr. Google Will See You Now - Patriots’ Soapbox 24/7 News Network | 11/27/2019

… to the other 200 companies it owns. November 12th: The Wall Street Journal reports via an anonymous ‘source’ within Google that the company has been accessing millions of patients’ personal health data alongside Ascension, the largest Catholic health system in the world, without patient consent. The deal between Google and Ascension authorizing the data transfer was formally signed, hours after The Wall Street Journal broke the story. The same day …

Google Alert - project | 11/21/2019

… Ask About Google’s Project Nightingale Slate Magazine On Nov. 11, the world learned about Project Nightingale—Google’s secretive deal with Ascension, the largest nonprofit health system in the United … Flag as irrelevant Virtual Assistant Offers … project for owners Sagamore Development and New York investment bank Goldman Sachs. Its office is currently located … Flag as irrelevant How Jessica Klein Turned a Passion Project Into Bondeye Jewelry Morning Brew Today, Bondeye is …

University of Texas MD Anderson Cancer Center

Global RNAi Therapeutics Market 2019-2030: Focus on siRNA, miRNA, shRNA and DNA | PR Newswire | 11/27/2019

… F-Prime Capital GeneCopoeia GeneCust GeneDesign GENEL Genentech GenePharma Genesis Pharmaceuticals Sanofi Genzyme / Genzyme Genomics England GlaxoSmithKline (GSK) Glycostem Therapeutics Goldman Sachs Gradalis Gritstone Oncology Guang’anmen Hospital of China Academy of Chinese Medical Sciences Harvard … Toxicology Legend Sky Investment Lincoln Park Capital Fund Lonza The University of Texas MD Anderson Cancer Center Mallinckrodt Pharmaceuticals Marina Biotech Massachusetts Institute of Technology Medison Pharma miRagen Therapeutics miReven MirImmune Mirimus Moderna Therapeutics Moore …

Global RNAi Therapeutics Market 2019-2030: Focus on siRNA, miRNA, shRNA and DNA | Markets Insider | Business Insider | 11/27/2019

… F-Prime Capital GeneCopoeia GeneCust GeneDesign GENEL Genentech GenePharma Genesis Pharmaceuticals Sanofi Genzyme / Genzyme Genomics England GlaxoSmithKline (GSK) Glycostem Therapeutics Goldman Sachs Gradalis Gritstone Oncology Guang’anmen Hospital of China Academy of Chinese Medical Sciences Harvard … Toxicology Legend Sky Investment Lincoln Park Capital Fund Lonza The University of Texas MD Anderson Cancer Center Mallinckrodt Pharmaceuticals Marina Biotech Massachusetts Institute of Technology Medison Pharma miRagen Therapeutics miReven MirImmune Mirimus Moderna Therapeutics Moore …

Harvard Medical School

Tuesday, November 26, 2019 | Kaiser Health News | 11/26/2019

… Chicago-based Outcome to raise $487.5 million of equity financing and borrow $485 million, with investors that included affiliates of Goldman Sachs Group Inc, Google parent Alphabet Inc and Pritzker Group. (Stempel, 11/25) Medicaid University … Unapproved Drug New research led by Dr. Pieter Cohen of Harvard Medical School documents five supplement brands for sale in the U.S. that contain various amounts of piracetam, a drug prescribed in European countries for …

A New Capitalist: An Immigrant Story | Forbes | 6/19/2019

… about how things worked in the world. So she moved to the business world – first on the healthcare desk at Goldman Sachs and then as a private equity investor at TPG Capital – and sat at … her MBA at Harvard Business School and is now attending Harvard Medical School, where she is able now to study with the help of financial aid from the Paul and Daisy Soros Fellowship for New …

Mount Sinai Medical Center

AllianceBernstein National Municipal Income Fund Releases Monthly Portfolio Update | PR Newswire | 11/22/2019

Goldman Sachs Group, Inc. (The)) Series 2017A 5.00%, 9/01/42 2.00% 5) Jefferson County Board of Education/AL Series 2018 5.00%, 2/01/46 1.72% 6) Wisconsin Public Finance Authority(CHF - Wilmington LLC) AGM 5.00%, 7/01/58 1.68% 7) Los Angeles Department of Water & Power Power System Revenue Series 2013B 5.00%, 7/01/30 1.65% 8) Detroit Downtown Development Authority AGM Series 2018A 5.00%, 7/01/48 1.61% 9) Miami Beach Health Facilities Authority (Mount Sinai Medical Center …

AllianceBernstein National Municipal Income Fund Releases Monthly Portfolio Update | Benzinga | 11/22/2019

Goldman Sachs Group, Inc. (The)) Series 2017A 5.00%, 9/01/42 2.00% 5) Jefferson County Board of Education/AL Series 2018 5.00%, 2/01/46 1.72% 6) Wisconsin Public Finance Authority(CHF - Wilmington LLC) AGM 5.00%, 7/01/58 1.68% 7) Los Angeles Department of Water & Power Power System Revenue Series 2013B 5.00%, 7/01/30 1.65% 8) Detroit Downtown Development Authority AGM Series 2018A 5.00%, 7/01/48 1.61% 9) Miami Beach Health Facilities Authority (Mount Sinai Medical Center …

HCA

Nov 19, 2019 - Equitable Trust Co Buys ARK Innovation ETF, MSCI Inc, PepsiCo Inc, Sells Elanco Animal Health Inc, HDFC Bank, Electronic Arts Inc - GuruFocus.com | 11/19/2019

Investment company Equitable Trust Co ( Current Portfolio ) buys ARK Innovation ETF, MSCI Inc, PepsiCo Inc, Allstate Corp, Goldman Sachs Group Inc, sells Elanco Animal Health Inc, HDFC Bank, Electronic Arts Inc, Aptiv PLC, Lowe’s Inc … ICE , CHYHY , FISV , BA , XOM , T , EBAY , WBA , KO , KKR , HCA , DG , PYPL , GIL , VC , VZ , AFL , BABA , BMY , SAP , O , PEG , PFE , NFLX , CLX , PNFP , ROP , ROST , CI , XBI , PM , CVS , TRV , UNH , MTDR …

HCA Healthcare (NYSE:HCA) Price Target Raised to $160.00 | 11/18/2019

HCA Healthcare (NYSE:HCA) Price Target Raised to $160.00 Posted by Rex Hubbard on Nov 18th, 2019 Tweet HCA Healthcare (NYSE:HCA) had its price target hoisted by Robert W. Baird from $155.00 to $160.00 … overweight rating in a research report on Wednesday, October 30th. Goldman Sachs Group upgraded HCA Healthcare from a neutral rating to a buy rating and lifted their price objective for the stock from $147.00 to …

HCA Healthcare

HCA Healthcare (NYSE:HCA) Price Target Raised to $160.00 | 11/18/2019

HCA Healthcare (NYSE:HCA) Price Target Raised to $160.00 Posted by Rex Hubbard on Nov 18th, 2019 Tweet HCA Healthcare (NYSE:HCA) had its price target hoisted by Robert W. Baird from $155.00 to $160.00 … overweight rating in a research report on Wednesday, October 30th. Goldman Sachs Group upgraded HCA Healthcare from a neutral rating to a buy rating and lifted their price objective for the stock from $147.00 to …

Nov 13, 2019 - Carret Asset Management, Llc Buys United Technologies Corp, eBay Inc, The Kraft Heinz Co, Sells Allergan PLC, Goldman Sachs Group Inc, Anadarko Petroleum Corp - GuruFocus.com | 11/13/2019

… Current Portfolio ) buys United Technologies Corp, eBay Inc, The Kraft Heinz Co, Unum Group, Blackstone Group Inc, sells Allergan PLC, Goldman Sachs Group Inc, Anadarko Petroleum Corp, Schlumberger, Vodafone Group PLC during Carret Asset Management … 42.29. 0.06%. The holding were 38,349 shares as of . Added: HCA Healthcare Inc ( HCA ) Carret Asset Management, Llc added to a holding in HCA Healthcare Inc by 78.50%. The purchase prices were between $117.4 and …

Clover Health

30 companies worth at least $1 billion that didn’t exist 10 years ago | Business Insider | 12/4/2019

… the company’s “toxic” environment. Since the scandal, Anthony Noto — former chief operating officer of Twitter and former managing director at Goldman Sachs — has taken over and shown interest in SoFi entering the cryptocurrency game . Scooter … is a ripe industry to disrupt, and San Francisco-based Clover Health knows it. The company, founded in 2014, is valued at $1.2 billion. Clover Health Clover Health’s incentive is to do away with paperwork …

30 companies worth at least $1 billion that didn’t exist 10 years ago | Markets Insider | Business Insider | 12/3/2019

… the company’s “toxic” environment. Since the scandal, Anthony Noto - former chief operating officer of Twitter and former managing director at Goldman Sachs - has taken over and shown interest in SoFi entering the cryptocurrency game . Scooter … is a ripe industry to disrupt, and San Francisco-based Clover Health knows it. The company, founded in 2014, is valued at $1.2 billion. Clover Health Clover Health’s incentive is to do away with paperwork …

Oscar Health

30 companies worth at least $1 billion that didn’t exist 10 years ago | Business Insider | 12/4/2019

… the company’s “toxic” environment. Since the scandal, Anthony Noto — former chief operating officer of Twitter and former managing director at Goldman Sachs — has taken over and shown interest in SoFi entering the cryptocurrency game . Scooter … quit the app over. New York-based health insurance startup Oscar Health was founded in 2012 and is worth $3.2 billion. Mario Schlosser, CEO and co-founder of Oscar speaks to guests during the TechCrunch …

30 companies worth at least $1 billion that didn’t exist 10 years ago | Markets Insider | Business Insider | 12/3/2019

… the company’s “toxic” environment. Since the scandal, Anthony Noto - former chief operating officer of Twitter and former managing director at Goldman Sachs - has taken over and shown interest in SoFi entering the cryptocurrency game . Scooter … quit the app over. New York-based health insurance startup Oscar Health was founded in 2012 and is worth $3.2 billion. Eduardo Munoz/Reuters Oscar raised $375 million from Alphabet last year, and said it …

Cigna

Tech Data Leaps (+12.32%) On Apollo Bid & Broad Markets Take It On Chin! Vista Partners Daily Market Recap 11/29/19 | 11/30/2019

… per share. Recently reports surfaced that publicly traded private equity firm KKR (KKR $29.49, -.94%) is preparing a buyout plan. Cigna (CI) closed at $199.92/share, -.05%. INVO Bioscience, Inc. (IVOB), a medical device company … after reporting results this week that missed expectations & lowered guidance. Goldman Sachs (GS) ($222.95/share, +.22%) recently downgraded CSCO as it views that corporate spending on technology has weakened. Disney (DIS) closed at $151.48/share …

Unexpected Key Data Points, AVX Corp (+18.97%), INVO Bioscience (+9.09%) & Broad Markets Rise! Vista Partners Daily Market Recap 11/27/19 | 11/28/2019

… per share. Recently reports surfaced that publicly traded private equity firm KKR (KKR $29.77, +.4%) is preparing a buyout plan. Cigna (CI) closed at $200.03/share, -.17%. Biotech The Ishares Nasdaq Biotechnology ETF (IBB) moved … after reporting results this week that missed expectations & lowered guidance. Goldman Sachs (GS) ($222.95/share, +.22%) recently downgraded CSCO as it views that corporate spending on technology has weakened. Disney (DIS) closed at $151.48/share …

Independent Health

Dr. Google Will See You Now - Patriots’ Soapbox 24/7 News Network | 11/27/2019

… success.” Let’s look at two strategies that Google is employing to control the health space and how it’s being carried out: Medical Freedom Censorship, Lies, & Smears Google is suppressing, de-ranking and ruining independent health sites like GreenMedinfo , HoneyColony , Mercola , & SelfHacked by making sure their A.I deems them unauthoratative while big corporate pharma websites like Web MD monopolize the first page of results, which is where many people stop their …

** | 11/12/2019**

… say they wish to mirror their customer base. Others are keen not to recruit from an artificially thin talent pool. Goldman Sachs claims its new entry-level recruitment targets—50% female and, in America, 14 … they were assessed by doctors.” Under the medivac legislation, an Independent Health Advice Panel has the final say on who can be transferred to Australia on medical grounds. The panel is made up of representatives …

Aetna

379 lgbtq friendly companies - Pastebin.com | 11/19/2019

A.L. Nella & Company, LLP, CPAs A.T. Kearney Aardema Whitelaw, PLLC Acacia Home LLC Accenture Aetna Inc. Air Products and Chemicals, Inc. AJ Leo Electric and Solar Akamai Technologies, Inc. Alaska Airlines Alcoa Inc. Amazon Services … Associates Claims Services Go Factory, Inc. Goethel Engelhardt, PLLC The Goldman Sachs Group, Inc. Google Inc. Goulston & Storrs, P.C. Great Officiants LLC The Greater Connecticut Gay and Lesbian Chamber of Commerce Greater San Diego Business …

CATASYS INC (CATS) Q3 2019 Earnings Call Transcript | The Motley Fool | 11/17/2019

… expected in 2020. In that regard, we are pleased to have closed on a $45 million debt financing commitment with Goldman Sachs, the proceeds of which will enable us to progress toward positive cash flow … As Terren touched on earlier, our OnTrak-A solution with Aetna expanded into six states, serving eligible members in Ohio, Tennessee, North Carolina, South Carolina, Maryland, and Delaware. We launched enrollment in Maryland and Delaware …

Anthem

Change Healthcare Appoints Ryan Miller as Senior Vice President, Corporate Development - Business Wire | 11/19/2019

Change Healthcare Appoints Ryan Miller as Senior Vice President, Corporate Development Download Ryan Miller, senior vice president of Corporate Development, Change Healthcare. (Photo: Business Wire) Ryan Miller, senior vice president of Corporate Development, Change Healthcare. (Photo: Business Wire) Thumbnail November 19, 2019 09:37 AM Eastern Standard Time NASHVILLE, Tenn.–( BUSINESS WIRE )–Today Change Healthcare (Nasdaq: CHNG) announced the appointment of Ryan Miller as senior vice president of Corporate Development. Mr …

Anthem Inc. Named One of America’s Most JUST Companies by Forbes and JUST Capital | Business Wire | 11/12/2019

INDIANAPOLIS–(BUSINESS WIRE)–Nov 12, 2019– Today, Anthem Inc. (NYSE: ANTM) was named one of America’s Most JUST Companies for 2020, according to Forbes and JUST Capital , one of the leading corporate measurement platforms for … All of America’s Most JUST Companies will be included in Goldman Sachs Asset Management’s JUST U.S. Large Cap Equity ETF (Ticker: JUST) – the first exchange-traded fund constructed from JUST Capital’s annual Rankings. About America’s …

Network Health

Forward Networks Unveils New In-App Network Query Engine (NQE) Checks | PR Newswire | 11/19/2019

… extended that capability with the release of In-App NQE Checks. The in-app capabilities provide custom check verifications on network health, proper configurations, and effects of a change. Customers are given more meaningful diagnosis … is headquartered in Palo Alto, California . Investors include Andreessen Horowitz, Goldman Sachs, Threshold, and A.Capital. For more information, visit forwardnetworks.com. SOURCE Forward Networks Related Links http://forwardnetworks.com …

5G May Not Help Verizon and AT&T But It Should Boost Qualcomm and Micron - Barron’s | 10/25/2019

… won’t be so important, after all. A few weeks ago, this column covered that shift in thinking . “We do not believe that 5G offers consumers much in the way of additional utility,” wrote Goldman Sachs analyst Rod Hall in a recent research note. Yeesh, what a Debbie Downer. Well, what about the carriers? They might not benefit, either. MoffettNathanson telecom analyst Craig Moffett shows that over the past nine years …

Molina Healthcare

Google Alert - Financial Markets | 11/17/2019

… measures. Flag as irrelevant Edited Transcript of APO earnings conference call or presentation 31-Oct-19 2:00pm GMT Yahoo Finance Goldman Sachs Group Inc., Research Division - Lead Capital Markets … and Martin Kelley, Chief Financial Officer … the financial markets and emerging growth companies, … Flag as irrelevant Molina Healthcare Inc (MOH) Soars 6.14% on November 15 Equities.com Molina Healthcare Inc (MOH) had a good day on the market for Friday … For more …

Week 46 Breakout Forecast: Short-Term Picks To Give You An Edge | Seeking Alpha | 11/11/2019

… Epizyme (EPZ) +11.86% Inspire Medical Systems ( INSP ) +11.98% TAL Education Group ( TAL ) +15.88% KEMET Corp ( KEM ) +26.88% uniQure ( QURE ) +7.41% Molina Healthcare ( MOH ) +3.92% Collegium Pharmaceuticals ( COLL ) +57.29% Zymeworks ( ZYME ) +56.78% StoneCo Ltd. ( STNE ) +17.18 … medium-term. Prior picks Caterpillar Inc. ( CAT ), Dow Inc. ( DOW ), Goldman Sachs ( GS ) remain strong positive breakout selections from prior weeks now up more than 25% for CAT, 24% for DOW, 11% for Goldman Sachs

Select Health

Health Catalyst Inc (HCAT) Q3 2019 Earnings Call Transcript | The Motley Fool | 11/13/2019

… will be revenue under contract from current clients. Anne Samuel – J.P. Morgan – Analyst That’s very helpful. Thanks guys. Patrick Nelli – Chief Financial Officer Thank you. Our next question comes from Robert Jones with Goldman Sachs. Your line is open. Robert Jones – Goldman Sachs – Analyst Great. Thanks for the questions. I guess maybe just a similar question. I know you guys in the past have talked about having fairly good visibility …

FinancialBuzz.com: ‘Market Recap’ Week Ending October 18th, 2019 | PR Newswire | 10/18/2019

… Average soared by over 300 points or 1.2% after upbeat earnings by JPMorgan Chase, Wells Fargo, Citigroup, UnitedHealth, and Johnson & Johnson. While most of the banks reported better-than-expected quarterly financial results, Goldman Sachs lagged behind after reporting disappointing quarterly results. Despite Goldman Sachs’ performance, the Dow Jones closed at a 3-week high. On Wednesday, markets were dragged lower on weaker-than-expected retail sales, which fell by …

Humana

CNO Financial Group, Inc. (CNO) CEO Gary Bhojwani on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha | 11/7/2019

… Call Participants Daniel Bergman - Citi Randy Binner - B. Riley FBR Erik Bass - Autonomous Research Humphrey Lee - Dowling & Partners Alex Scott - Goldman Sachs Alex Scott - Goldman Sachs Thomas Gallagher - Evercore ISI Operator Ladies and gentlemen, thank … products and services including a new Medicare advantage pilot with Humana in our direct-to-consumer channel expanding to the right to slightly younger wealthier consumers within the middle income market and deploying excess capital …

Humana’s (HUM) CEO Bruce Broussard on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha | 11/6/2019

Humana, Inc. (NYSE: HUM ) Q3 2019 Earnings Conference Call November 6, 2019 9:00 AM ET Company Participants Amy Smith – Vice President-Investor Relations Bruce Broussard – President and Chief Executive Officer Brian Kane – Chief Financial Officer Conference Call Participants Ralph Giacobbe – Citi David Windley – Jefferies Peter Costa – Wells Fargo Charles Rhyee – Cowen Kevin Fischbeck – Bank of America Scott Fidel – Stephens Sarah James – Piper Jaffray Josh Raskin – Nephron Research Stephen Tanal – Goldman …

Andrew Cuomo

Goldman Sachs | 2/24/2020

Difference between revisions of “Goldman Sachs” From SourceWatch + ‘'’Goldman Sachs’’’, founded in 1869, promotes itself as a “leading global investment banking, securities and investment management firm that provides a wide range of services worldwide.” ref … bailout funds prompting an investigation by New York Attorney General Andrew Cuomo. Benefits to Goldman Sachs of AIG Bailout + Some financial analysts have argued that in calculating Goldman Sachs’ government bailout, the total should include …

23 November - Blogs I’m Following - 1 of 5 | 11/24/2019

… SCOTUS – Justice Ruth Bader Ginsburg was admitted to Johns Hopkins Hospital in Baltimore, Maryland, … Continue reading → Navy Secretary and Former Goldman Sachs Executive, Richard Spencer, Denies Threatening President Trump… sundance at The Last Refuge - 2 … a broader gaming compact between the Tuscarora Nation and Governor Andrew Cuomo that would authorize a second Las Vegas-style casino in downtown Niagara Falls. Sources Laundry Disruptor – Rudy Giuliani Sends Letter to Senator Graham …

Donald Trump

TPS Consulting Daily | 12/4/2019

… Capital. The San Mateo based … SoftBank pours $100 million into Mexico’s Konfio – TechCrunch Shared by TechCrunch techcrunch.com - Three months after Goldman Sachs lent $100 million to Mexican fintech Konfio, SoftBank has invested another $100 million … Nansen Malin morningconsult.com - Regardless of what one thinks about President Donald Trump, we should all be able to agree that he has been right to insist that U.S. trade policy should serve America’s interests first …

Elizabeth Warren

House Democrats Poised to Rubber-Stamp Weak Financial Regulation | 12/4/2019

… American Bankers Association and the four banks that dominate the swaps market — J.P. Morgan Chase, Bank of America, Citigroup, and Goldman Sachs — contributed $218,000 to agriculture committee members. The same group of donors gave more … the swaps pushout rule. A handful of Senate Democrats, including Elizabeth Warren, threatened to vote down the bill if the provision wasn’t removed. But Democratic leadership and the White House were ultimately willing to sacrifice …

AWS Works Hard To Keep Ahead Of The Public Cloud Herd | 12/4/2019

… are other large players with deep pockets, notably Alibaba and Tencent. AWS can count a lot of major corporations – GE, Goldman Sachs, Capital One, Pfizer and Shell, to name a few – as customers as well … the strength of AWS’ innovation engine. It’s like AWS is Elizabeth Warren for the cloud: if there is a problem, AWS has a plan for that. And the resources . In the third quarter, AWS generated …

Bernie Sanders

TPS Consulting Daily | 12/4/2019

… Capital. The San Mateo based … SoftBank pours $100 million into Mexico’s Konfio – TechCrunch Shared by TechCrunch techcrunch.com - Three months after Goldman Sachs lent $100 million to Mexican fintech Konfio, SoftBank has invested another $100 million … Billions of Dollars Shared by Chris From WI breitbart.com - Sen. Bernie Sanders (I-VT) on Monday took another shot at billionaire Michael Bloomberg, remarking that the “dumbest person on Earth” could run for president if …

Joe Biden

TPS Consulting Daily | 12/4/2019

… Capital. The San Mateo based … SoftBank pours $100 million into Mexico’s Konfio – TechCrunch Shared by TechCrunch techcrunch.com - Three months after Goldman Sachs lent $100 million to Mexican fintech Konfio, SoftBank has invested another $100 million … un Shared by Chris From WI breitbart.com - Former Vice President Joe Biden kicked off his “No Malarkey” tour of Iowa over the weekend by lying about having “spent a lot of time” with North Korean …

Jeff Bezos

30 companies worth at least $1 billion that didn’t exist 10 years ago | Business Insider | 12/4/2019

… the company’s “toxic” environment. Since the scandal, Anthony Noto — former chief operating officer of Twitter and former managing director at Goldman Sachs — has taken over and shown interest in SoFi entering the cryptocurrency game . Scooter … shoes, and CEO Joey Zwillinger penned an open letter to Jeff Bezos asking the company to “please steal our approach to sustainability.” As for the future of Allbirds, founders of Tim Brown and Joey Zwillinger …

MAYOR PETE BUTTIGIEG DECLARES THAT HIS HEALTH PLAN WILL INCLUDE ILLEGALS AND HIS AMNESTY WILL ENABLE THE REST OF MEXICO TO JUMP U.S. OPEN BORDERS AND VOTE DEM FOR MORE | 12/3/2019

… throughout the month of November, including commentaries and editorials in the Times and the Washington Post (owned by Amazon billionaire Jeff Bezos), an op-ed from former Treasury Secretary Lawrence Summers, and public statements from … Reviews Obama Is Making You Poorer—But Who’s Getting Rich? Goldman Sachs, GE, Pfizer, the United Auto Workers—the same “special interests” Barack Obama was supposed to chase from the temple—are profiting handsomely from …

Elon Musk

Larry Page steps down at Alphabet; Sundar Pichai to lead both Alphabet, Google as CEO | Yahoo News | 12/4/2019

… of artificial intelligence on society. He’s also an investor in Tesla ( TSLA ), the electric car company founded and led by Elon Musk. Google’s stock, traded on the Nasdaq, rose modestly in after-hours trading from … for Yahoo Finance. Follow Javier on Twitter: @TeflonGeek Read more: Goldman Sachs: Trump has ‘narrow’ shot in ‘close call’ election bid Jim Chanos on Tesla: Cars are ‘poorly made’ — but you can’t fire Elon Musk

Bill Gates

30 companies worth at least $1 billion that didn’t exist 10 years ago | Business Insider | 12/4/2019

… the company’s “toxic” environment. Since the scandal, Anthony Noto — former chief operating officer of Twitter and former managing director at Goldman Sachs — has taken over and shown interest in SoFi entering the cryptocurrency game . Scooter … singer Katy Perry, tennis star Serena Williams, and Microsoft cofounder Bill Gates. At the end of 2018, the company said it was turning out a million pounds of the product every month — and there are …

MAYOR PETE BUTTIGIEG DECLARES THAT HIS HEALTH PLAN WILL INCLUDE ILLEGALS AND HIS AMNESTY WILL ENABLE THE REST OF MEXICO TO JUMP U.S. OPEN BORDERS AND VOTE DEM FOR MORE | 12/3/2019

… Amazon billionaire Jeff Bezos), an op-ed from former Treasury Secretary Lawrence Summers, and public statements from billionaires Warren Buffett, Bill Gates, Mark Cuban and Leon Cooperman, all attacking proposals by Warren and Sanders for … Reviews Obama Is Making You Poorer—But Who’s Getting Rich? Goldman Sachs, GE, Pfizer, the United Auto Workers—the same “special interests” Barack Obama was supposed to chase from the temple—are profiting handsomely from …

Mark Zuckerberg

A US citizen was arrested for visiting North Korea and giving a talk on cryptocurrencies. An expert says such knowledge is hugely valuable to the hermit kingdom. | 12/4/2019

… that varies depending on what state you live in, your insurance, and the type of birth you have. Read More » Goldman Sachs is assembling a team of senior bankers focused on middle-market private equity … Sapphire Preferred thanks to its perks and rewards. Read More » Mark Zuckerberg spent almost $60 million on 2 waterfront estates in Tahoe last winter. Here’s a look at the 10 properties he owns across the …

MAYOR PETE BUTTIGIEG DECLARES THAT HIS HEALTH PLAN WILL INCLUDE ILLEGALS AND HIS AMNESTY WILL ENABLE THE REST OF MEXICO TO JUMP U.S. OPEN BORDERS AND VOTE DEM FOR MORE | 12/3/2019

… that audience, given that several of the candidates are all but pledging to put those companies out of business. Should Mark Zuckerberg, founder of Facebook, go vote for Elizabeth Warren, who can’t stop singling him … Reviews Obama Is Making You Poorer—But Who’s Getting Rich? Goldman Sachs, GE, Pfizer, the United Auto Workers—the same “special interests” Barack Obama was supposed to chase from the temple—are profiting handsomely from …

Pete Buttigieg

TPS Consulting Daily | 12/4/2019

… Capital. The San Mateo based … SoftBank pours $100 million into Mexico’s Konfio – TechCrunch Shared by TechCrunch techcrunch.com - Three months after Goldman Sachs lent $100 million to Mexican fintech Konfio, SoftBank has invested another $100 million … officers, a police chief said. Officers performed lif… Fact Check: Pete Buttigieg Says Illegal Aliens ‘Subsidizing Everybody Else’ Shared by Chris From WI breitbart.com - Illegal migrants are subsidizing Americans, Pete Buttigieg told a December 1 …